SCHEMBL16826684

SCHEMBL16826684

CC(C)(C)OC(=O)N1CCN(Nc2nnc(Cl)c(N)n2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.43
▸ MAP4K4 O95819 1/20 0.41
▸ SMARCA2 P51531 1/20 0.40
▸ SMARCA4 P51532 1/20 0.40
▸ PBRM1 Q86U86 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PTPN11 Q06124 1/20 0.40
▸ STS P08842 1/20 0.40
▸ HTT P42858 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ F13A1 P00488 2/20 0.38
▸ TGM2 P21980 2/20 0.38
▸ TGM1 P22735 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16854562 0.85 ALDH1A1 (0.50) POLBHTTNPC1ALDH1A1MAPT
SCHEMBL16826782 0.82 BTK (0.41) POLBMAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL16854515 0.80 PTPN11 (0.51) POLBMAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL16826859 0.74 PARP1 (0.39) POLBMAP4K4MEN1KMT2AALDH1A1
SCHEMBL16826739 0.73 GPR119 (0.46) POLBMAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL16826873 0.72 POLB (0.38) POLBMAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL16853964 0.71 GPR119 (0.45) MAP4K4SMARCA2SMARCA4PBRM1PTPN11
SCHEMBL24690538 0.70 ALDH1A1 (0.55) MEN1KMT2ASTSHTTF13A1
SCHEMBL16826745 0.70 SMARCA2 (0.40) POLBMAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL16826747 0.70 SMARCA2 (0.40) POLBMAP4K4SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844076-B2 Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine NEKTAR THERAPEUTICS (US) 2020-11-24 — — US disclosed
US-20190071454-A1 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE NEKTAR THERAPEUTICS 2019-03-07 — — US disclosed
US-10189859-B2 Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine NEKTAR THERAPEUTICS (US) 2019-01-29 — — US disclosed
US-20170066782-A1 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE NEKTAR THERAPEUTICS 2017-03-09 — — US disclosed
WO-2015092819-A2 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5- AMINE NEKTAR THERAPEUTICS (INDIA) PVT. LTD. (IN) 2015-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844076-B2 Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine KCNJ2, TRPC5, RYR2 POLB 4480/4885MAP4K4 680/4885SMARCA2 3438/4885
US-20190071454-A1 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE KCNJ2, TRPC5, RYR2 POLB 4480/4885MAP4K4 680/4885SMARCA2 3438/4885
US-20170066782-A1 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE KCNJ2, TRPC5, RYR2 POLB 4480/4885MAP4K4 680/4885SMARCA2 3438/4885
US-10189859-B2 Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine KCNJ2, TRPC5, RYR2 POLB 4480/4885MAP4K4 680/4885SMARCA2 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback